Jan 10, 2022 / NTS GMT
Masashi Miyamoto - Kyowa Kirin Co., Ltd. - President, CEO & Representative Director
I am Masashi Miyamoto, President and the CEO of Kyowa Kirin. It's a great honor to participate in the JPMorgan Health care conference. As this is the first time Kyowa Kirin is presenting at this conference, I'd like to take this opportunity to talk about who we are, our contribution to science and the patients and our vision towards our future. All my comments must be qualified by this statement. This is today's agenda, and let me start from who we are. We are Japan-based global specialty pharmaceutical company with a vision shown here. We will realize the successful creation and the delivery of life-changing value that ultimately makes people smile, as a Japan-based global specialty pharmaceutical company built on the diverse team of experts with a shared passion for innovation.
In order to make this vision a reality by 2030, we focus on provide pharmaceuticals for unmet medical needs, address patient-centric healthcare needs and retain the trust of a society.
Here is the overview of Kyowa Kirin in 2020,
Kyowa Kirin Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers